1. Home
  2. MARA vs CRSP Comparison

MARA vs CRSP Comparison

Compare MARA & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marathon Digital Holdings Inc.

MARA

Marathon Digital Holdings Inc.

HOLD

Current Price

$13.23

Market Cap

5.4B

Sector

Technology

ML Signal

HOLD

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$62.06

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MARA
CRSP
Founded
2010
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.9B
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
MARA
CRSP
Price
$13.23
$62.06
Analyst Decision
Buy
Buy
Analyst Count
12
17
Target Price
$17.85
$70.29
AVG Volume (30 Days)
40.5M
1.5M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$907,093,000.00
$289,590,000.00
Revenue This Year
N/A
$807.72
Revenue Next Year
$13.31
$172.52
P/E Ratio
N/A
N/A
Revenue Growth
38.20
9169.85
52 Week Low
$6.66
$44.12
52 Week High
$23.45
$78.48

Technical Indicators

Market Signals
Indicator
MARA
CRSP
Relative Strength Index (RSI) 47.89 69.76
Support Level $11.68 $47.48
Resistance Level $13.80 $75.06
Average True Range (ATR) 1.28 3.09
MACD -0.22 0.82
Stochastic Oscillator 29.78 90.86

Price Performance

Historical Comparison
MARA
CRSP

About MARA Marathon Digital Holdings Inc.

MARA Holdings Inc leverages digital asset computing to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value. The company also offers technology solutions to optimize data center operations, including next-generation liquid immersion cooling and firmware for Bitcoin miners. It is focused on computing for, acquiring, and holding digital assets as a long-term investment.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: